ID

13711

Beschreibung

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01466790

Link

https://clinicaltrials.gov/show/NCT01466790

Stichworte

Versionen (1)
  1. 29.02.16 29.02.16 -
Hochgeladen am

29. Februar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis C NCT01466790

Englisch

Eligibility Hepatitis C NCT01466790

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic genotype 1 hepatitis c virus (hcv) infection
Beschreibung

chronic hepatitis c

Datentyp

boolean

Alias
UMLS CUI [1]
C0524910
plasma hcv rna of more than 10,000 iu/ml at screening
Beschreibung

plasma hepatitis c virus rna

Datentyp

boolean

Alias
UMLS CUI [1]
C1977893
patients in cohort 1 must be null responders to pegifn/ribavirin with at least 1 documented previous course of pegifn/ribavirin therapy for at least 12 consecutive weeks
Beschreibung

therapy ribavirin; therapy response for hepatitis c virus infection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0035525
UMLS CUI [2]
C2750389
patients in cohort 2 must be null responders to pegifn/ribavirin with at least 1 documented previous course of pegifn/ribavirin therapy for at least 12 consecutive weeks and could also be hcv treatment-naive, meaning never received treatment with any approved or investigational drug for the treatment of hcv
Beschreibung

therapy response for hepatitis c virus infection; Therapy naive Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1]
C2750389
UMLS CUI [2,1]
C0919936
UMLS CUI [2,2]
C0019196
null responders patients in cohort 1 and cohort 2 must meet the defined criterion for a null responder, defined as on-treatment less than 2 log10 iu/ml reduction in hcv rna from baseline at week 12 of the most recent pegifn/ribavirin therapy
Beschreibung

hepatitis c virus; cohort; no response to treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0220847
UMLS CUI [2]
C0599755
UMLS CUI [3]
C0184782
patient must have had a liver biopsy within 3 years before screening (or between screening and baseline visit) or patient must have had a liver biopsy at any time in the past which showed metavir f3 or f4 fibrosis
Beschreibung

liver biopsy; screening; metavir fibrosis score

Datentyp

boolean

Alias
UMLS CUI [1]
C0193388
UMLS CUI [2]
C0220908
UMLS CUI [3]
C3897040
must agree to use 2 forms of effective contraception throughout the study (male and female)
Beschreibung

contraception

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
has evidence of hepatic decompensation
Beschreibung

hepatic decompensation

Datentyp

boolean

Alias
UMLS CUI [1]
C0085605
has any liver disease of non-hcv etiology
Beschreibung

liver disease; etiology

Datentyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C1314792
has an infection/co-infection with non-genotype 1 hcv
Beschreibung

HCV coinfection; hcv genotype

Datentyp

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2]
C1148363
has a co-infection with human immunodeficiency virus (hiv) type 1 or type 2 (hiv-1 or hiv-2) (positive hiv-1 or hiv-2 antibody test at screening)
Beschreibung

coinfection hiv; hiv antibody test

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0275524
UMLS CUI [2]
C2229753
has a co-infection with hepatitis b virus (hepatitis b surface antigen [hbsag] positive)
Beschreibung

HBV coinfection; Hepatitis B surface antigen positive

Datentyp

boolean

Alias
UMLS CUI [1]
C2242656
UMLS CUI [2]
C0149709
has a history of malignancy within 5 years of the screening visit
Beschreibung

medical history malignancy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0006826
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis C NCT01466790

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
chronic hepatitis c
Item
chronic genotype 1 hepatitis c virus (hcv) infection
boolean
C0524910 (UMLS CUI [1])
plasma hepatitis c virus rna
Item
plasma hcv rna of more than 10,000 iu/ml at screening
boolean
C1977893 (UMLS CUI [1])
therapy ribavirin; therapy response for hepatitis c virus infection
Item
patients in cohort 1 must be null responders to pegifn/ribavirin with at least 1 documented previous course of pegifn/ribavirin therapy for at least 12 consecutive weeks
boolean
C0087111 (UMLS CUI [1,1])
C0035525 (UMLS CUI [1,2])
C2750389 (UMLS CUI [2])
therapy response for hepatitis c virus infection; Therapy naive Hepatitis C
Item
patients in cohort 2 must be null responders to pegifn/ribavirin with at least 1 documented previous course of pegifn/ribavirin therapy for at least 12 consecutive weeks and could also be hcv treatment-naive, meaning never received treatment with any approved or investigational drug for the treatment of hcv
boolean
C2750389 (UMLS CUI [1])
C0919936 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
hepatitis c virus; cohort; no response to treatment
Item
null responders patients in cohort 1 and cohort 2 must meet the defined criterion for a null responder, defined as on-treatment less than 2 log10 iu/ml reduction in hcv rna from baseline at week 12 of the most recent pegifn/ribavirin therapy
boolean
C0220847 (UMLS CUI [1])
C0599755 (UMLS CUI [2])
C0184782 (UMLS CUI [3])
liver biopsy; screening; metavir fibrosis score
Item
patient must have had a liver biopsy within 3 years before screening (or between screening and baseline visit) or patient must have had a liver biopsy at any time in the past which showed metavir f3 or f4 fibrosis
boolean
C0193388 (UMLS CUI [1])
C0220908 (UMLS CUI [2])
C3897040 (UMLS CUI [3])
contraception
Item
must agree to use 2 forms of effective contraception throughout the study (male and female)
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hepatic decompensation
Item
has evidence of hepatic decompensation
boolean
C0085605 (UMLS CUI [1])
liver disease; etiology
Item
has any liver disease of non-hcv etiology
boolean
C0023895 (UMLS CUI [1])
C1314792 (UMLS CUI [2])
HCV coinfection; hcv genotype
Item
has an infection/co-infection with non-genotype 1 hcv
boolean
C1698259 (UMLS CUI [1])
C1148363 (UMLS CUI [2])
coinfection hiv; hiv antibody test
Item
has a co-infection with human immunodeficiency virus (hiv) type 1 or type 2 (hiv-1 or hiv-2) (positive hiv-1 or hiv-2 antibody test at screening)
boolean
C0019682 (UMLS CUI [1,1])
C0275524 (UMLS CUI [1,2])
C2229753 (UMLS CUI [2])
HBV coinfection; Hepatitis B surface antigen positive
Item
has a co-infection with hepatitis b virus (hepatitis b surface antigen [hbsag] positive)
boolean
C2242656 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
medical history malignancy
Item
has a history of malignancy within 5 years of the screening visit
boolean
C0262926 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video